1. Home
  2. VERA vs DV Comparison

VERA vs DV Comparison

Compare VERA & DV Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • VERA
  • DV
  • Stock Information
  • Founded
  • VERA 2016
  • DV 2008
  • Country
  • VERA United States
  • DV United States
  • Employees
  • VERA N/A
  • DV N/A
  • Industry
  • VERA Biotechnology: Pharmaceutical Preparations
  • DV Computer Software: Prepackaged Software
  • Sector
  • VERA Health Care
  • DV Technology
  • Exchange
  • VERA Nasdaq
  • DV Nasdaq
  • Market Cap
  • VERA 2.0B
  • DV 2.4B
  • IPO Year
  • VERA 2021
  • DV 2021
  • Fundamental
  • Price
  • VERA $23.20
  • DV $14.88
  • Analyst Decision
  • VERA Buy
  • DV Buy
  • Analyst Count
  • VERA 8
  • DV 18
  • Target Price
  • VERA $64.63
  • DV $18.92
  • AVG Volume (30 Days)
  • VERA 1.3M
  • DV 2.3M
  • Earning Date
  • VERA 08-07-2025
  • DV 08-05-2025
  • Dividend Yield
  • VERA N/A
  • DV N/A
  • EPS Growth
  • VERA N/A
  • DV N/A
  • EPS
  • VERA N/A
  • DV 0.29
  • Revenue
  • VERA N/A
  • DV $681,128,000.00
  • Revenue This Year
  • VERA N/A
  • DV $15.65
  • Revenue Next Year
  • VERA N/A
  • DV $11.67
  • P/E Ratio
  • VERA N/A
  • DV $50.96
  • Revenue Growth
  • VERA N/A
  • DV 15.30
  • 52 Week Low
  • VERA $18.53
  • DV $11.52
  • 52 Week High
  • VERA $51.61
  • DV $23.11
  • Technical
  • Relative Strength Index (RSI)
  • VERA 49.75
  • DV 51.13
  • Support Level
  • VERA $22.57
  • DV $14.56
  • Resistance Level
  • VERA $24.58
  • DV $15.66
  • Average True Range (ATR)
  • VERA 1.13
  • DV 0.38
  • MACD
  • VERA 0.06
  • DV -0.06
  • Stochastic Oscillator
  • VERA 38.05
  • DV 36.07

About VERA Vera Therapeutics Inc.

Vera Therapeutics Inc is a clinical stage biotechnology company. It is focused on developing and commercializing transformative treatments for patients with serious immunological diseases. The company's product candidate is atacicept, a fusion protein self-administered as a subcutaneous injection once weekly that blocks both B lymphocyte stimulator and a proliferation-inducing ligand, which stimulate B cells and plasma cells to produce autoantibodies contributing to certain autoimmune diseases.

About DV DoubleVerify Holdings Inc.

DoubleVerify Holdings Inc is a digital media measurement and analytics software platform. Its solutions provide advertisers with unbiased data analytics that enable them to increase the effectiveness, quality, and return on their digital advertising investments. Its DV Authentic Ad, a proprietary metric of digital media quality, measures whether a digital ad was delivered in a brand-suitable environment, fully viewable, by a real person, and in the intended geography. The company's software interface, DV Pinnacle, delivers these metrics to customers in real time, allowing them to access critical performance data on their digital transactions. Geographically, the company operates in the United States and also has a presence in Germany, Singapore, France, Canada, Japan, and other countries.

Share on Social Networks: